Vivek Vijay1,2,3, Susan P Mollan4, James L Mitchell1,2,3, Edward Bilton4, Zerin Alimajstorovic1, Keira A Markey1,3, Anthony Fong4,5, Jessica K Walker4, Hannah S Lyons4, Andreas Yiangou1,2,3, Georgios Tsermoulas6, Kristian Brock7, Alexandra J Sinclair1,2,3. 1. Metabolic Neurology, Institute of Metabolism and Systems Research, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom. 2. Centre for Endocrinology, Diabetes and Metabolism, Birmingham Health Partners, Birmingham, United Kingdom. 3. Department of Neurology, Queen Elizabeth Hospital, University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom. 4. Birmingham Neuro-Ophthalmology, Ophthalmology Department, Queen Elizabeth Hospital, University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom. 5. Department of Medicine, The University of Queensland, Herston, Queensland, Australia. 6. Department of Neurosurgery, Queen Elizabeth Hospital, University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom. 7. Institute of Cancer and Genomic Sciences, University of Birmingham, Edgbaston, Birmingham, United Kingdom.
Abstract
Importance: There is an unmet need for noninvasive biomarkers of intracranial pressure (ICP), which manifests as papilledema that can be quantified by optical coherence tomography (OCT) imaging. Objective: To determine whether OCT of the optic nerve head in papilledema could act as a surrogate measure of ICP. Design, Setting, and Participants: This longitudinal cohort study used data collected from 3 randomized clinical trials that were conducted between April 1, 2014, and August 1, 2019. Participants who were female and had active idiopathic intracranial hypertension were enrolled from 5 National Health Service hospitals in the UK. Automated perimetry and OCT imaging were followed immediately by ICP measurement on the same day. Cohort 1 used continuous sitting telemetric ICP monitoring (Raumedic Neurovent P-tel device) on 1 visit. Cohort 2 was evaluated at baseline and after 3, 12, and 24 months and underwent lumbar puncture assessment of ICP. Main Outcomes and Measures: Optical coherence tomography measures of the optic nerve head and macula were correlated with ICP levels, Frisén grading, and perimetric mean deviation. The OCT protocol included peripapillary retinal nerve fiber layer, optic nerve head, and macular volume scans (Spectralis [Heidelberg Engineering]). All scans were validated for quality and resegmented manually when required. Results: A total of 104 women were recruited. Among cohort 1 (n = 15; mean [SD] age, 28.2 [9.4] years), the range of OCT protocols was evaluated, and optic nerve head central thickness was found to be most closely associated with ICP (right eye: r = 0.60; P = .02; left eye: r = 0.73; P = .002). Subsequently, findings from cohort 2 (n = 89; mean [SD] age, 31.8 [7.5] years) confirmed the correlation between central thickness and ICP longitudinally (12 and 24 months). Finally, bootstrap surrogacy analysis noted a positive association between central thickness and change in ICP at all points (eg, at 12 months, a decrease in central thickness of 50 μm was associated with a decrease in ICP of 5 cm H2O). Conclusions and Relevance: In this study, optic nerve head volume measures on OCT (particularly central thickness) reproducibly correlated with ICP and surrogacy analysis demonstrated its ability to inform ICP changes. These data suggest that OCT has the utility to not only monitor papilledema but also noninvasively prognosticate ICP levels in idiopathic intracranial hypertension.
Importance: There is an unmet need for noninvasive biomarkers of intracranial pressure (ICP), which manifests as papilledema that can be quantified by optical coherence tomography (OCT) imaging. Objective: To determine whether OCT of the optic nerve head in papilledema could act as a surrogate measure of ICP. Design, Setting, and Participants: This longitudinal cohort study used data collected from 3 randomized clinical trials that were conducted between April 1, 2014, and August 1, 2019. Participants who were female and had active idiopathic intracranial hypertension were enrolled from 5 National Health Service hospitals in the UK. Automated perimetry and OCT imaging were followed immediately by ICP measurement on the same day. Cohort 1 used continuous sitting telemetric ICP monitoring (Raumedic Neurovent P-tel device) on 1 visit. Cohort 2 was evaluated at baseline and after 3, 12, and 24 months and underwent lumbar puncture assessment of ICP. Main Outcomes and Measures: Optical coherence tomography measures of the optic nerve head and macula were correlated with ICP levels, Frisén grading, and perimetric mean deviation. The OCT protocol included peripapillary retinal nerve fiber layer, optic nerve head, and macular volume scans (Spectralis [Heidelberg Engineering]). All scans were validated for quality and resegmented manually when required. Results: A total of 104 women were recruited. Among cohort 1 (n = 15; mean [SD] age, 28.2 [9.4] years), the range of OCT protocols was evaluated, and optic nerve head central thickness was found to be most closely associated with ICP (right eye: r = 0.60; P = .02; left eye: r = 0.73; P = .002). Subsequently, findings from cohort 2 (n = 89; mean [SD] age, 31.8 [7.5] years) confirmed the correlation between central thickness and ICP longitudinally (12 and 24 months). Finally, bootstrap surrogacy analysis noted a positive association between central thickness and change in ICP at all points (eg, at 12 months, a decrease in central thickness of 50 μm was associated with a decrease in ICP of 5 cm H2O). Conclusions and Relevance: In this study, optic nerve head volume measures on OCT (particularly central thickness) reproducibly correlated with ICP and surrogacy analysis demonstrated its ability to inform ICP changes. These data suggest that OCT has the utility to not only monitor papilledema but also noninvasively prognosticate ICP levels in idiopathic intracranial hypertension.
Authors: Philipp Albrecht; Christine Blasberg; Marius Ringelstein; Ann-Kristin Müller; David Finis; Rainer Guthoff; Ella-Maria Kadas; Wolf Lagreze; Orhan Aktas; Hans-Peter Hartung; Friedemann Paul; Alexander U Brandt; Axel Methner Journal: J Neurol Date: 2017-06-05 Impact factor: 4.849
Authors: Linda D'Antona; James A McHugh; Federico Ricciardi; Lewis W Thorne; Manjit S Matharu; Laurence D Watkins; Ahmed K Toma; Fion D Bremner Journal: JAMA Neurol Date: 2019-12-01 Impact factor: 18.302
Authors: Prejaas Tewarie; Lisanne Balk; Fiona Costello; Ari Green; Roland Martin; Sven Schippling; Axel Petzold Journal: PLoS One Date: 2012-04-19 Impact factor: 3.240
Authors: Falko Kaufhold; Ella Maria Kadas; Christoph Schmidt; Hagen Kunte; Jan Hoffmann; Hanna Zimmermann; Timm Oberwahrenbrock; Lutz Harms; Konrad Polthier; Alexander U Brandt; Friedemann Paul Journal: PLoS One Date: 2012-05-15 Impact factor: 3.240
Authors: Xiaoxuan Liu; Aditya Uday Kale; Nicholas Capewell; Nicholas Talbot; Sumiya Ahmed; Pearse A Keane; Susan Mollan; Antonio Belli; Richard J Blanch; Tonny Veenith; Alastair K Denniston Journal: BMJ Open Date: 2019-11-07 Impact factor: 2.692
Authors: Andrew G Lee; Thomas H Mader; C Robert Gibson; William Tarver; Pejman Rabiei; Roy F Riascos; Laura A Galdamez; Tyson Brunstetter Journal: NPJ Microgravity Date: 2020-02-07 Impact factor: 4.415
Authors: Keira Annie Markey; Ryan Ottridge; James L Mitchell; Caroline Rick; Rebecca Woolley; Natalie Ives; Peter Nightingale; Alexandra J Sinclair Journal: JMIR Res Protoc Date: 2017-09-18
Authors: Ryan Ottridge; Susan P Mollan; Hannah Botfield; Emma Frew; Natalie J Ives; Tim Matthews; James Mitchell; Caroline Rick; Rishi Singhal; Rebecca Woolley; Alexandra J Sinclair Journal: BMJ Open Date: 2017-09-27 Impact factor: 2.692
Authors: Mark Thaller; Victoria Homer; Yousef Hyder; Andreas Yiangou; Anthony Liczkowski; Anthony W Fong; Jasvir Virdee; Rachel Piccus; Marianne Roque; Susan P Mollan; Alexandra J Sinclair Journal: J Neurol Date: 2022-10-15 Impact factor: 6.682
Authors: Olivia Grech; Andrew Clouter; James L Mitchell; Zerin Alimajstorovic; Ryan S Ottridge; Andreas Yiangou; Marianne Roque; Abd A Tahrani; Matthew Nicholls; Angela E Taylor; Fozia Shaheen; Wiebke Arlt; Gareth G Lavery; Kimron Shapiro; Susan P Mollan; Alexandra J Sinclair Journal: Brain Commun Date: 2021-09-02
Authors: Henrik Holvin Jacobsen; Øystein Kalsnes Jørstad; Morten C Moe; Goran Petrovski; Are Hugo Pripp; Tiril Sandell; Per Kristian Eide Journal: Transl Vis Sci Technol Date: 2022-01-03 Impact factor: 3.283
Authors: Andreas Yiangou; James L Mitchell; Matthew Nicholls; Yu Jeat Chong; Vivek Vijay; Benjamin R Wakerley; Gareth G Lavery; Abd A Tahrani; Susan P Mollan; Alexandra J Sinclair Journal: J Neurol Date: 2021-08-22 Impact factor: 4.849